ELDN · NASDAQ
Eledon Pharmaceuticals (ELDN) Stock Price & Fundamentals
Eledon Pharmaceuticals (ELDN) closed at $620.17 on Oct 9, 2026, down 0.65% from the previous close of $624.22.
Share price, past year
1Y −0.06%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $620.17 |
| Sep 30, 2026 | $631.17 |
| Aug 31, 2026 | $625.04 |
| Jul 31, 2026 | $649.88 |
| Jun 30, 2026 | $644.04 |
| May 29, 2026 | $627.66 |
| Apr 30, 2026 | $606.65 |
| Mar 31, 2026 | $588.44 |
| Feb 27, 2026 | $660.63 |
| Jan 30, 2026 | $673.05 |
| Dec 31, 2025 | $653.87 |
| Nov 28, 2025 | $620.48 |
| Oct 31, 2025 | $589.51 |
Key statistics
- Market cap
- $50.17B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.91
- Revenue (TTM)
- —
- Net income (TTM)
- −$98.56M
- Shares outstanding
- 80.9M
- Dividend yield
- —
- 52-week range
- $582.97 – $676.54
Eledon Pharmaceuticals's market cap is $50.17B, based on a share price of $620.17 and 80.9M shares outstanding as of Jun 30, 2026.
Financials
Eledon Pharmaceuticals reported revenue of $0.00 for fiscal 2016.
Eledon Pharmaceuticals reported a net loss of $45.62M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2016ended Dec 31, 2016 | $0.00 | — | −$5.66M | — | −$2.46 | — |
| FY2015ended Dec 31, 2015 | $0.00 | — | — | — | — | — |
| FY2014ended Dec 31, 2014 | $0.00 | — | — | — | — | — |
| FY2013ended Dec 31, 2013 | $0.00 | — | — | — | — | — |
| FY2012ended Dec 31, 2012 | $0.00 | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2017ended Mar 31, 2017 | $0.00 | — | — |
| Q4 FY2016ended Dec 31, 2016 | $0.00 | — | — |
| Q3 FY2016ended Sep 30, 2016 | $0.00 | — | — |
| Q2 FY2016ended Jun 30, 2016 | $0.00 | — | — |
| Q1 FY2016ended Mar 31, 2016 | $0.00 | — | — |
| Q4 FY2015ended Dec 31, 2015 | $0.00 | — | — |
| Q3 FY2015ended Sep 30, 2015 | $0.00 | — | — |
| Q2 FY2015ended Jun 30, 2015 | $0.00 | — | — |
Company profile
- Name
- Eledon Pharmaceuticals, Inc.
- Ticker
- ELDN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 19800 Macarthur Blvd., Suite 250, Irvine, CA 92612
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001404281
Recent SEC filings
- Aug 13, 2026
- Aug 13, 2026
- Jun 22, 2026
- May 13, 2026
- May 13, 2026
- Mar 19, 2026
- Mar 19, 2026
- Jan 2, 2026
Frequently asked questions
What is Eledon Pharmaceuticals's stock price?
Eledon Pharmaceuticals (ELDN) closed at $620.17 on Oct 9, 2026, down 0.65% from the previous close of $624.22.
What is Eledon Pharmaceuticals's market cap?
Eledon Pharmaceuticals's market cap is $50.17B, based on a share price of $620.17 and 80.9M shares outstanding as of Jun 30, 2026.
How much revenue does Eledon Pharmaceuticals make?
Eledon Pharmaceuticals reported revenue of $0.00 for fiscal 2016.
Does Eledon Pharmaceuticals pay a dividend?
Eledon Pharmaceuticals's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Eledon Pharmaceuticals, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures